Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An acute myeloid leukemia associated with t(8;21)(q22;q22) resulting in RUNX1-RUNX1T1 fusion protein expression. The bone marrow and the peripheral blood show large myeloblasts with abundant basophilic cytoplasm, often containing azurophilic granules.
No clinical trials have been registered for acute myeloid leukemia, t(8;21)(q22; q22.1).
2 publications have been identified in PubMed for acute myeloid leukemia, t(8;21)(q22; q22.1). Research spans Case Report / Case Series (50%) and Basic Science / Preclinical (50%).
Yamada Y (2026). [PMID: 41658852](https://pubmed.ncbi.nlm.nih.gov/41658852/). *Cureus*. [Case Report / Case Series]
Zhang W (2024). [PMID: 38702444](https://pubmed.ncbi.nlm.nih.gov/38702444/). *Int J Hematol*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:43 AM UTC
Common questions about acute myeloid leukemia, t(8;21)(q22; q22.1)